Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

174.92
Delayed Data
As of May 22
 -2.09 / -1.18%
Today’s Change
119.37
Today|||52-Week Range
189.48
+36.61%
Year-to-Date

Today’s Trading

Previous close177.01
Today’s open176.36
Day’s range174.49 - 176.50
Volume1,176,618
Average volume (3 months)1,013,028
Market cap$25.9B
Dividend yield--
Data as of 3:59pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.08%
Earnings growth (next 5 years)+14.41%
Revenue growth (last year)+8.05%
P/E ratio35.3
Price/Sales7.90
Price/Book11.78

Competitors

 Today’s
change
Today’s
% change
BIVVBioverativ Inc-0.17-0.31%
NBIXNeurocrine Bioscienc...+0.85+1.61%
KITEKite Pharma Inc+0.86+1.22%
TECHBio-Techne Corp+0.39+0.35%
Data as of 4:14pm ET, 05/22/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$0.70
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Chief Financial Officer &
Senior Vice President
Sam A. Samad
Corporate headquarters
San Diego, California

Forecasts